Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy
Description: NARRATIVE There is an unmet clinical need to develop novel therapeutic agents for the treatment of the head and neck squamous cell carcinoma (HNSCC). Thus, this application's primary goal is to discover the fundamental vulnerabilities of HNSCC for the development of mechanism-based therapeutic drugs or strategies.
Funding type: research
Funder scheme: R01
Start date: 2005-04-01
End date: 2026-07-31
Investigator: BESIM OGRETMEN
Institution: MEDICAL UNIVERSITY OF SOUTH CAROLINA
Funded outputs count: 83
Funder award ID: R01DE016572
OpenAlex ID: G9000878829
